Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Inflammatory bowel disease.

Podolsky DK.

N Engl J Med. 2002 Aug 8;347(6):417-29. Review. No abstract available.

PMID:
12167685
2.

[Drug therapy of inflammatory bowel diseases].

Silvennoinen J, Niemelä S.

Duodecim. 1999;115(20):2233-8. Review. Finnish. No abstract available.

PMID:
11973927
3.

[Chronic inflammatory bowel diseases. Update on evidence-based therapy].

[No authors listed]

MMW Fortschr Med. 2005 Apr 28;147(17):58-9. German. No abstract available.

PMID:
15903063
4.

[Changing treatment of inflammatory bowel diseases].

Karvonen AL, Matikainen M, Turunen U.

Duodecim. 1994;110(20):1945-54. Review. Finnish. No abstract available.

PMID:
7555809
5.

[Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].

Schölmerich J.

Internist (Berl). 1997 Jun;38(6):582-9. Review. German. No abstract available.

PMID:
9265003
6.

Management of inflammatory bowel disease.

Botoman VA, Bonner GF, Botoman DA.

Am Fam Physician. 1998 Jan 1;57(1):57-68, 71-2. Review.

7.

Current medical therapy for inflammatory bowel disease.

Bonner GF.

South Med J. 1996 Jun;89(6):556-66. Review.

PMID:
8638193
8.

An evidence-based systematic review on medical therapies for inflammatory bowel disease.

Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P; American College of Gastroenterology IBD Task Force..

Am J Gastroenterol. 2011 Apr;106 Suppl 1:S2-25; quiz S26. doi: 10.1038/ajg.2011.58. Review. No abstract available.

PMID:
21472012
9.

Medical treatment of inflammatory bowel disease.

Singhal A, Kar P.

J Assoc Physicians India. 1995 Sep;43(9):627-31. Review. No abstract available.

PMID:
8773067
10.

Conventional medical management of inflammatory bowel disease.

Burger D, Travis S.

Gastroenterology. 2011 May;140(6):1827-1837.e2. doi: 10.1053/j.gastro.2011.02.045. Review.

PMID:
21530749
11.

[Therapy of chronic inflammatory bowel diseases].

Beglinger C.

Ther Umsch. 1997 Nov;54(11):649-53. Review. German.

PMID:
9454368
12.

[Possibilities of drug treatment in inflammatory intestinal diseases].

van Hogezand RA, Lamers CB.

Ned Tijdschr Geneeskd. 1994 Dec 17;138(51):2536-40. Review. Dutch. No abstract available.

PMID:
7830801
13.

Inflammatory bowel disease.

Hanauer SB.

N Engl J Med. 1996 Mar 28;334(13):841-8. Review. No abstract available. Erratum in: N Engl J Med 1996 Jul 11;335(2):143.

PMID:
8596552
14.

Clinical pharmacology of inflammatory bowel disease therapies.

Sandborn WJ, Faubion WA.

Curr Gastroenterol Rep. 2000 Dec;2(6):440-5. Review.

PMID:
11079044
15.

Newer treatments for inflammatory bowel disease.

Stotland BR, Lichtenstein GR.

Prim Care. 1996 Sep;23(3):577-608. Review.

PMID:
8888346
16.

The use of medications for inflammatory bowel disease during pregnancy and nursing.

Sauk J, Kane S.

Expert Opin Pharmacother. 2005 Sep;6(11):1833-9. Review.

PMID:
16144504
17.

[Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].

Hellström PM, Schmidt D, Karlén P.

Lakartidningen. 2007 Oct 10-16;104(41):2973-6. Review. Swedish. No abstract available.

PMID:
17977308
18.

Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.

Ramos JM, García-Sepulcre MF, Masiá M, Brotons A, Grau MC, Gutiérrez F.

Rev Esp Enferm Dig. 2010 Oct;102(10):614-6. No abstract available.

19.

Adverse events of IBD therapies.

Scribano ML.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S210-1. doi: 10.1002/ibd.20702. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816669
20.

[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].

Geboes K, Desreumaux P, Jouret A, Ectors N, Rutgeerts P, Colombel JF.

Gastroenterol Clin Biol. 1999 Oct;23(10):1062-73. Review. French. No abstract available.

Supplemental Content

Support Center